VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $26,809,000 | -30.9% | 1,870,814 | -16.5% | 0.20% | -38.3% |
| Q2 2017 | $38,774,000 | +20.1% | 2,241,254 | -23.4% | 0.32% | +23.7% |
| Q1 2017 | $32,284,000 | +47.2% | 2,926,941 | +93.8% | 0.26% | +44.0% |
| Q4 2016 | $21,932,000 | -34.9% | 1,510,494 | +10.0% | 0.18% | -41.7% |
| Q3 2016 | $33,704,000 | -41.1% | 1,372,888 | -51.6% | 0.31% | -41.9% |
| Q2 2016 | $57,185,000 | -1.2% | 2,839,364 | +29.1% | 0.54% | +0.9% |
| Q1 2016 | $57,860,000 | +8787.9% | 2,200,000 | +60141.0% | 0.53% | +6550.0% |
| Q3 2015 | $651,000 | -1.5% | 3,652 | -20.9% | 0.01% | -27.3% |
| Q4 2014 | $661,000 | -91.9% | 4,619 | -92.9% | 0.01% | -94.0% |
| Q2 2014 | $8,204,000 | +1.6% | 65,047 | +6.2% | 0.18% | -18.0% |
| Q1 2014 | $8,075,000 | – | 61,250 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |